{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:56:58Z","timestamp":1787673418890,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004192","name":"National Science and Technology Development Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004192","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.surg.2019.10.013","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T09:17:54Z","timestamp":1574327874000},"page":"560-568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Hepatic glypican-3 and alpha-smooth muscle actin overexpressions reflect severity of liver fibrosis and predict outcome after successful portoenterostomy in biliary atresia"],"prefix":"10.1016","volume":"167","author":[{"given":"Wanvisa","family":"Udomsinprasert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Napat","family":"Angkathunyakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naruemon","family":"Klaikeaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paisarn","family":"Vejchapipat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Poovorawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sittisak","family":"Honsawek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2019.10.013_bib1","first-page":"193","article-title":"Biliary atresia: 10 year-experience at Chulalongkorn University Hospital","volume":"40","author":"Chandrakamol","year":"1996","journal-title":"Chula Med J"},{"key":"10.1016\/j.surg.2019.10.013_bib2","first-page":"253","article-title":"Association of vitamin D-related genetic variations and the susceptibility among Thai children with biliary atresia","volume":"63","author":"Sirisomboonlarp","year":"2019","journal-title":"Chula Med J"},{"key":"10.1016\/j.surg.2019.10.013_bib3","first-page":"865","article-title":"Maximizing Kasai portoenterostomy in the treatment of biliary atresia: medical and surgical options","volume":"102","author":"Davenport","year":"2012","journal-title":"S\u00a0Afr Med J"},{"key":"10.1016\/j.surg.2019.10.013_bib4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1172\/JCI200113712","article-title":"Glypicans: proteoglycans with a surprise","volume":"108","author":"Filmus","year":"2001","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.surg.2019.10.013_bib5","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/labinvest.3700479","article-title":"The oncofetal protein glypican-3 is a novel marker of hepatic progenitor\/oval cells","volume":"86","author":"Grozdanov","year":"2006","journal-title":"Lab Invest"},{"key":"10.1016\/j.surg.2019.10.013_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0304-4165(02)00390-2","article-title":"The role of glypicans in mammalian development","volume":"1573","author":"Song","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.surg.2019.10.013_bib7","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/modpathol.2010.105","article-title":"Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation","volume":"23","author":"Ward","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.surg.2019.10.013_bib8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/modpathol.2008.37","article-title":"Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma","volume":"21","author":"Aviel-Ronen","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.surg.2019.10.013_bib9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2559.2006.02522.x","article-title":"Hepatocellular oncofetal protein, glypican 3 is a sensitive marker for alpha-fetoprotein\u2013producing gastric carcinoma","volume":"49","author":"Hishinuma","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.surg.2019.10.013_bib10","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/gut.48.4.558","article-title":"Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders","volume":"48","author":"Zhu","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.surg.2019.10.013_bib11","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1158\/0008-5472.CAN-04-4244","article-title":"Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling","volume":"65","author":"Capurro","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.surg.2019.10.013_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0006-291X(03)00908-2","article-title":"Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker","volume":"306","author":"Nakatsura","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.surg.2019.10.013_bib13","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1083\/jcb.109.6.2929","article-title":"Cellular distribution of smooth muscle actins during mammalian embryogenesis: expression of the alpha-vascular but not the gamma-enteric isoform in differentiating striated myocytes","volume":"109","author":"Sawtell","year":"1989","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.surg.2019.10.013_bib14","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/MPG.0b013e3182680be3","article-title":"\u03b1-SMA overexpression associated with increased liver fibrosis in infants with biliary atresia","volume":"55","author":"Dong","year":"2012","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.surg.2019.10.013_bib15","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/s41390-019-0370-3","article-title":"CD82 supports survival of childhood acute myeloid leukemia cells via activation of Wnt\/\u03b2-catenin signaling pathway","volume":"85","author":"Ji","year":"2019","journal-title":"Pediatr Res"},{"key":"10.1016\/j.surg.2019.10.013_bib16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.surg.2019.10.013_bib17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2353\/ajpath.2009.081129","article-title":"Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation","volume":"175","author":"Liu","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.surg.2019.10.013_bib18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/hep.21952","article-title":"Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate","volume":"47","author":"Decaens","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.surg.2019.10.013_bib19","first-page":"458","article-title":"Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells","volume":"44","author":"Li","year":"2006","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"10.1016\/j.surg.2019.10.013_bib20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ijc.10856","article-title":"Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling","volume":"103","author":"Midorikawa","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.surg.2019.10.013_bib21","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/modpathol.2009.40","article-title":"Glypican-3 expression in clear cell adenocarcinoma of the ovary","volume":"22","author":"Maeda","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.surg.2019.10.013_bib22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000136159","article-title":"Immunohistochemical study of glypican 3 in thyroid cancer","volume":"73","author":"Yamanaka","year":"2007","journal-title":"Oncology"},{"key":"10.1016\/j.surg.2019.10.013_bib23","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/j.1349-7006.2009.01206.x","article-title":"Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma","volume":"100","author":"Shirakawa","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.surg.2019.10.013_bib24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/hep.27081","article-title":"WNT\/\u03b2-catenin signaling and hepatocellular carcinoma","volume":"60","author":"Wands","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.surg.2019.10.013_bib25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.dld.2004.11.009","article-title":"Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation","volume":"37","author":"Carpino","year":"2005","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.surg.2019.10.013_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/petr.12834","article-title":"The histological quantification of alpha-smooth muscle actin predicts future graft fibrosis in pediatric liver transplant recipients","volume":"21","author":"Varma","year":"2017","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.surg.2019.10.013_bib27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jss.2013.12.010","article-title":"The glypican 3 hepatocellular carcinoma marker regulates human hepatic stellate cells via Hedgehog signaling","volume":"187","author":"Magistri","year":"2014","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.surg.2019.10.013_bib28","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/labinvest.3700349","article-title":"Role for hedgehog signaling in hepatic stellate cell activation and viability","volume":"85","author":"Sicklick","year":"2005","journal-title":"Lab Invest"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606019307342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606019307342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:53:43Z","timestamp":1758538423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606019307342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0039606019307342"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2019.10.013","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic glypican-3 and alpha-smooth muscle actin overexpressions reflect severity of liver fibrosis and predict outcome after successful portoenterostomy in biliary atresia","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2019.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}